Wacker Chemie has announced plans to invest “a double-digit million euro amount” on it the new Biotechnology Centre at its corporate research facility in Munich, which is due to be operational in 2024. CEO Christian Hartel said that building it “will allow us to concentrate and intensify our research activities in the area of biotechnology. The additional capacity we will create here will accelerate the growth of our life-sciences division.”

We sum up the latest developments in one of the industry's hottest fields

There have been multiple recent announcements across the world about investments in cleaner forms of hydrogen. These mainly refer to ‘green hydrogen’ produced by electrolysis, though also ‘blue hydrogen’, which is made from natural gas in a reforming process, in which CO₂ emissions are captured for storage.

Chemical companies continue to invest in hand sanitiser in response to the Covid-19 pandemic. A large number of them are now producing in significant volumes.

Ineos, the largest European producer of the two key raw materials - isopropyl alcohol (IPA) and ethanol – has announced its intention to produce 1 million bottles of hand sanitiser/month from each of three newly built facilities in the UK, Germany and France.